These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 865824)

  • 21. The vinca alkaloids.
    O'Marcaigh AS; Betcher DL
    J Pediatr Oncol Nurs; 1995 Jul; 12(3):140-2. PubMed ID: 7646834
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
    Takasugi BJ; Jones SE; Robertone AB
    Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of vinzolidine.
    Budman DR; Schulman P; Marks M; Vinciguerra V; Weiselberg L; Kreis W; Degnan TJ
    Cancer Treat Rep; 1984; 68(7-8):979-82. PubMed ID: 6744350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports.
    Chan JD
    Pharmacotherapy; 1998; 18(6):1304-7. PubMed ID: 9855331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and role of vinca-alkaloids in the treatment of metastatic breast cancers].
    Herrera A; Delgado FM; Besenval M; Merle S; Badri N; Marty M; Krikorian A
    Pathol Biol (Paris); 1990 Oct; 38(8):860-1. PubMed ID: 2274391
    [No Abstract]   [Full Text] [Related]  

  • 28. [Foundations of the therapy of inoperable malignomas and hemoblastoses].
    Stacher A
    Wien Med Wochenschr; 1976 Jan; 126(5):51-4. PubMed ID: 948909
    [No Abstract]   [Full Text] [Related]  

  • 29. Vinca alkaloids. Experimental and clinical trials.
    Klener P
    Acta Univ Carol Med Monogr; 1974; (58):1-157. PubMed ID: 4374079
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vincristine in the treatment of thrombocytopenia in five dogs.
    Greene CE; Scoggin J; Thomas JE; Barsanti JA
    J Am Vet Med Assoc; 1982 Jan; 180(2):140-3. PubMed ID: 7061310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery systems and combination therapy by using vinca alkaloids.
    Lee CT; Huang YW; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1491-500. PubMed ID: 25877096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms.
    Stolinsky DC; Hum GJ; Jacobs EM; Solomon J; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):477-80. PubMed ID: 4586954
    [No Abstract]   [Full Text] [Related]  

  • 35. [New antitumor derivatives of vinblastine].
    Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with vinblastine and vincristine].
    Cipriani D
    Cancro; 1968; 21():Suppl 6:185-9. PubMed ID: 5264169
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.
    Stanley AJ; Kaprielian R; Retsas S
    Anticancer Res; 1993; 13(1):31-2. PubMed ID: 8476226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy of malignant tumors. V. Alkaloids].
    Beran M; Semonský M; Semonská S
    Cesk Farm; 1979 Jun; 28(5):217-20. PubMed ID: 509569
    [No Abstract]   [Full Text] [Related]  

  • 40. Biological characterization of human tumours by means of organ culture and individualized cytostatic cancer treatment.
    Tanneberger S; Mohr A
    Arch Geschwulstforsch; 1973; 42(4):307-15. PubMed ID: 4802948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.